Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Imatinib/interferon alpha

Enteric toxicity and JAK2 mutated polycythaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lapietra G, et al. Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events. Leukemia Research 126: Mar 2023. Available from: URL: http://doi.org/10.1016/j.leukres.2023.107035 Lapietra G, et al. Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events. Leukemia Research 126: Mar 2023. Available from: URL: http://​doi.​org/​10.​1016/​j.​leukres.​2023.​107035
Metadaten
Titel
Imatinib/interferon alpha
Enteric toxicity and JAK2 mutated polycythaemia: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45258-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Dacomitinib

Case report

Dapagliflozin

Case report

Multiple drugs